Oncotelic Therapeutics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Vuong Trieu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.8yrs |
| CEO ownership | 24.5% |
| Management average tenure | 5yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$5m |
| Jun 30 2024 | n/a | n/a | -US$1m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | n/a | n/a | -US$8m |
| Sep 30 2023 | n/a | n/a | -US$12m |
| Jun 30 2023 | n/a | n/a | -US$13m |
| Mar 31 2023 | n/a | n/a | US$9m |
| Dec 31 2022 | US$129k | US$38k | US$5m |
| Sep 30 2022 | n/a | n/a | US$9m |
| Jun 30 2022 | n/a | n/a | US$8m |
| Mar 31 2022 | n/a | n/a | -US$11m |
| Dec 31 2021 | US$257k | US$190k | -US$9m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$8m |
| Dec 31 2020 | US$216k | US$169k | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$10m |
| Jun 30 2020 | n/a | n/a | -US$9m |
| Mar 31 2020 | n/a | n/a | -US$10m |
| Dec 31 2019 | US$259k | US$115k | -US$7m |
Compensation vs Market: Insufficient data to establish whether Vuong's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Vuong's compensation has been consistent with company performance over the past year.
CEO
Vuong Trieu (61 yo)
10.8yrs
Tenure
Dr. Vuong Trieu, Ph.D. serves as the co-founder, President, Chairman and Chief Executive Officer of Oncotelic Inc. Dr. Trieu serves as Chairman and Chief Executive Officer of Oncotelic Therapeutics, Inc (f...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 10.8yrs | no data | 24.47% $ 2.5m | |
| Chief Financial Officer | 5.3yrs | no data | 0.088% $ 9.1k | |
| Chief Medical Officer – Translation Medicine & Director | 4.6yrs | no data | 0.28% $ 28.9k | |
| CBO & GM of AI Division | 5yrs | no data | 4.05% $ 417.6k | |
| Consultant & Director | no data | no data | 0% $ 0 | |
| Chief Scientific Officer | no data | no data | 5.77% $ 595.2k | |
| Chief Regulatory Officer & Chief Medical Officer | 2.5yrs | no data | no data | |
| CTO of AI Division | no data | no data | no data |
5.0yrs
Average Tenure
61yo
Average Age
Experienced Management: OTLC's management team is seasoned and experienced (5 years average tenure).